Description
A potent, selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 48.3, and 45.5nM for human CB1 and human CB2 receptors, respectively; displays antihyperalgesic and antiallodynic effects against thermal or mechanical stimuli in rat models of chronic neuropathic; orally acitve